Professor Mojisola Adeyeye

Director General National Agency for Food and Drug Administration and Control (NAFDAC)

Professor Adeyeye is the founding Chair of Biopharmaceutical Sciences and Professor of Pharmaceutics and Drug Product Evaluation at the College of Pharmacy, Roosevelt University in Schaumburg, Illinois.

She was Professor of Pharmaceutics and Manufacturing for 21 years at Duquesne University in Pittsburgh, PA. She is Senior Fulbright Scholar and Specialist and 2008 AAPS Fellow. She earned her B.S., and M.S., and PhD from the University of Nigeria, Nsukka, Nigeria and University of Georgia, Athens, GA, respectively.

Her research interests include preformulation, early phase development of solid, semisolid and liquid dosage forms, and IND-based and intellectual property-driven late phase development or bench-to-bedside translational research. She has mentored over 15 PhD and M.S candidates.

She has 5 patents, 55 peer-reviewed manuscripts, book chapters and books, and more than 140 scientific presentations. She is the founder of a socially conscious start-up company – Elim Pediatric Pharmaceuticals. She uses her university lab for the early phase R&D and partners with contract manufacturing organizations for the clinical and registration batches. She a mission and non-profit organization founded Drugs AIDS and HIV Patients and Sarah’s Orphan Homes.

See Professor Mojisola Adeyeye at this event

  • Webinar 2 Thursday 2 October

Session 3: Perspectives and progress for the inclusion of under-represented populations in clinical trials

14:30 - 16:00 CET

Panel discussion

  • Mojisola Adeyeye, Director General of National Agency for Food and Drug Administration and Control (NAFDAC)
  • Jean Marie Vianney Habarugira, Senior Scientific Officer, EDCTP3
  • Richa Chandra, Clinical Development Head, Global Health, Novartis on behalf of IFPMA
  • Runcie Chidebe, Founder, Project PINK BLUE